Poster Session 2-21 Multiple Myeloma: Basic/Translational Research

[PS2-21-7] Tissue inhibitor of metalloproteinases (TIMP) is associated with myeloma progression, prognosis

Rei Ishihara¹, Tsukasa Oda³, Masanobu Sunaga¹, Eiko Yamane¹, Yuki Murakami¹, Saki Watanabe¹, Yuta Asao¹, Hisashi Takei², Nobuhiko Kobayashi², Yohei Osaki², Morio Matsumoto⁴, Nanami Gotoh¹, Tetsuhiro Kasamatsu¹, Hiroaki Shimizu², Takuma Ishizaki², Hiromi Koiso², Makiko Takizawa², Hirono Iriuchishima², Tomomi Sekigami⁵, Akihiko Yokohama⁵, Norifumi Tsukamoto⁶, Yuta Masuda^1,7, Maaya Awata¹, Kana Souma^1,2, Nao Hashimoto¹, Hirokazu Murakami⁷, Takayuki Saito^1,7, Hiroshi Handa^1,2 (1.Gunma University Graduate School of Health Science, Gunma, Japan, 2.Department of Hematology, Gunma University School of Medicine, Gunma, Japan, 3.Institute of Molecular and Cellular Regulation, Gunma, Japan, 4.National Hospital Organization Shibukawa Medical Center, Gunma, Japan, 5.Blood Transfusion Service, Gunma University Hospital, Gunma, Japan, 6.Oncology Center, Gunma University Hospital, Gunma, Japan, 7.Gunma University of Health and Welfare)